Miniatura

Fitxers

695646.pdf (836.27 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-09-10

Llicència de publicació

cc-by (c) Ribera, I. et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/164265

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/s12887-019-1689-y

Resum

BACKGROUND: Congenital heart disease (CHD) is the most prevalent congenital malformation affecting 1 in 100 newborns. While advances in early diagnosis and postnatal management have increased survival in CHD children, worrying long-term outcomes, particularly neurodevelopmental disability, have emerged as a key prognostic factor in the counseling of these pregnancies. METHODS: Eligible participants are women presenting at 20 to < 37 weeks of gestation carrying a fetus with CHD. Maternal/neonatal recordings are performed at regular intervals, from the fetal period to 24 months of age, and include: placental and fetal hemodynamics, fetal brain magnetic resonance imaging (MRI), functional echocardiography, cerebral oxymetry, electroencephalography and serum neurological and cardiac biomarkers. Neurodevelopmental assessment is planned at 12 months of age using the ages and stages questionnaire (ASQ) and at 24 months of age with the Bayley-III test. Target recruitment is at least 150 cases classified in three groups according to three main severe CHD groups: transposition of great arteries (TGA), Tetralogy of Fallot (TOF) and Left Ventricular Outflow Tract Obstruction (LVOTO). DISCUSSION: The results of NEURO-HEART study will provide the most comprehensive knowledge until date of children's neurologic prognosis in CHD and will have the potential for developing future clinical decisive tools and improving preventive strategies in CHD.

Matèries

Malalties hereditàries, Malalts cardíacs, Trastorns per dèficit d'atenció amb hiperactivitat en els infants, Embaràs

Matèries (anglès)

Genetic diseases, Cardiac patients, Attention deficit disorder with hyperactivity in children, Pregnancy

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)

Citació

RIBERA, I., RUIZ, A., SÁNCHEZ, O., EIXARCH ROCA, Elisenda, ANTOLÍN, Eugenia, GÓMEZ-MONTES, M., PÉREZ-CRUZ, M., CRUZ LEMINI, Mónica cristina, SANZ CORTÉS, Magdalena, ARÉVALO, S., FERRER, Q., VÁZQUEZ, E., VEGA, L., DOLADER, P., MONTOLIU, A., BOIX, H., SIMÕES, Rui v., MASOLLER, N., SÁNCHEZ DE TOLEDO, José, COMAS, M., BARTHA, José luis, GALINDO, A., MARTÍNEZ CRESPO, Josep m. (josep maria), GÓMEZ ROIG, Ma. dolores, CRISPI BRILLAS, Fàtima, GÓMEZ, Olga, CARRERAS, E., CABERO, L., GRATACÓS SOLSONA, Eduard, LLURBA OLIVÉ, Elisa. Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.. _BMC Pediatrics_. 2019. Vol. 19, núm. 1, pàgs. 326. [consulta: 24 de gener de 2026]. ISSN: 1471-2431. [Disponible a: https://hdl.handle.net/2445/164265]

Exportar metadades

JSON - METS

Compartir registre